Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Randomized Double-Blind Phase II/III Study on the Safety and Immunogenicity of Three Vaccinations With TICOVAC in Two Dosages in Healthy Children Aged Between Six Months and Three Years

NCT00161746 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00161746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00161746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Randomized Double-Blind Phase II/III Study on the Safety and Immunogenicity of Three Vaccinations With TICOVAC in Two Dosages in Healthy Children Aged Between Six Months and Three Years
Lead sponsor
Pfizer
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 1998
Completion date
June 30, 1999
Enrollment
Not reported
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

encephalitis, tick-borne